Natures Sunshine Products Inc
NATR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000275053
In the last 90 days, Natures Sunshine Products Inc insiders filed 2 open-market purchases and 0 sales; 153 institutions reported holding it in 13F filings for Q2 2026, worth $343.6M in total; no superinvestor holds it.
Holders of 5% or more of NATR
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Natures Sunshine Products Inc, largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Natures Sunshine Products Inc on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
2 Schedule 13D and 13G filings on Natures Sunshine Products Inc, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Jun 27, 20254:15 PM ET | Shanghai Fosun Pharmaceutical (Group) Co., Ltd.and 1 other | 13D/A | 0.35%64.2K shares | −15.55 ppfrom 15.90%Below 5% | Jun 25, 2025 | SEC |
| Jun 9, 20254:30 PM ET | Shanghai Fosun Pharmaceutical (Group) Co., Ltd.and 1 other | 13D/A | 15.90%2.92M shares | – | Jun 5, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Natures Sunshine Products Inc shares.
No Form 144 notices for Natures Sunshine Products Inc are on file.